Consolidation in the generics sector
Graham Fraser-Pye, PLIVA Pharma Limited
Is the generics market due for a quiet period following the most recent spate of M&A activity? With rumours abounding of further mergers at a global and regional level it would appear not – in fact the pace looks set to continue unabated as more brands come off patent. But are we all chasing the same dream and how sustainable is it?
Mind the gap: integrating business development
Irina Serdobova, Axensus Limited, and Jonathan E Freeman, Baxter Healthcare, SA
Internal productivity remains lacklustre in the healthcare sector and competition for externally derived assets is rising accordingly. Meanwhile, the complexity of deal structuring has increased. A three-step, constraint-driven theory approach provides invaluable guidance in integrating effective business development into an organisation’s strategy.
Communicating during cross-cultural negotiations
Andrew Gottschalk, Group AG
Executives actively engaged in international, cross-border business transactions frequently express considerable concern about the levels of communication that exist within the negotiating process – particularly the global reliance on ‘business English’. This article analyses the problems inherent in such linguistic muddling and provides some recommendations.
How inaccurate self-reporting affects your business liability
Ben Wilcox and Joseph Braido, PricewaterhouseCoopers
Most life science organisations have a large number of contractual agreements (such as licensing, co-promotion, co-development, co-marketing, supply, joint venture and contract manufacturing), with a wide variety of business partners. These agreements are likely to have many undetected reporting issues which could either result in additional payments to partners or additional revenue for your company.
Competitive intelligence: when ignorance is not bliss
Gael L’Heveder, Roche
The competitive intelligence (CI) function has undergone a dramatic transformation over the past decade, from being a reactive information provider to becoming the privileged partner of senior management in elaborating and implementing strategies. CI has evolved into a proactive function intimately engaged in key strategic processes, particularly in contributing to corporate development.
Termination: intellectual property and related issues
Jennifer Pierce, Charles Russell LLP
Termination clauses are increasingly important in licence negotiation; they are now among the most contentious provisions in the whole agreement. In particular, intellectual property clauses are becoming more significant and it is crucial to balance the needs of both parties to avoid an adverse effect on the rest of the contract and possibly on the entire venture.
|
